- Report
- September 2026
- 199 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- September 2026
- 184 Pages
Global
From €3261EUR$3,545USD£2,778GBP
€3623EUR$3,939USD£3,087GBP
- Report
- May 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- July 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- February 2026
- 250 Pages
Global
From €4130EUR$4,490USD£3,519GBP
- Report
- August 2026
- 120 Pages
Global
From €4369EUR$4,750USD£3,722GBP
- Report
- March 2026
- 137 Pages
Global
From €3500EUR$4,076USD£3,086GBP
- Report
- August 2026
- 160 Pages
Global
From €3054EUR$3,320USD£2,602GBP
€3817EUR$4,150USD£3,252GBP
- Report
- August 2024
- 150 Pages
Global
From €3449EUR$3,750USD£2,939GBP
- Report
- June 2025
- 92 Pages
Global
From €3500EUR$4,076USD£3,086GBP
- Report
- July 2025
- 150 Pages
Global
From €4461EUR$4,850USD£3,801GBP
- Report
- September 2024
- 117 Pages
Global
From €4139EUR$4,500USD£3,526GBP
- Report
- August 2025
- 150 Pages
Global
From €2907EUR$3,160USD£2,476GBP
€3633EUR$3,950USD£3,095GBP
The Synthetic Biomaterial market is a subset of the larger Biomaterials market, which encompasses materials used in medical and healthcare applications. Synthetic Biomaterials are man-made materials that are designed to interact with biological systems, such as the human body. These materials are used in a variety of medical applications, including implants, prosthetics, and drug delivery systems. Synthetic Biomaterials are designed to be biocompatible, meaning they are non-toxic and do not cause an immune response. They are also designed to be durable and long-lasting, allowing them to be used in a variety of medical applications.
Some companies in the Synthetic Biomaterial market include Corbion, PolyOne Corporation, Evonik Industries, Solvay, and BASF. Show Less Read more
